{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:52:30Z","timestamp":1790358750070,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973524"],"award-info":[{"award-number":["81973524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66817-2","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:15:45Z","timestamp":1764836145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["KY216-tubulin complex captures VASH2 to inhibit NSCLC metastasis"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiao-Yu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-9086","authenticated-orcid":false,"given":"Xin-Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Mei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8222-9316","authenticated-orcid":false,"given":"Yong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-2618","authenticated-orcid":false,"given":"Ling-Yi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-5184","authenticated-orcid":false,"given":"Yuan-Zheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"66817_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA A Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA A Cancer J. Clin."},{"key":"66817_CR2","doi-asserted-by":"crossref","unstructured":"Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449\u2013458 (2006).","DOI":"10.1038\/nrc1886"},{"key":"66817_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ctrv.2013.10.001","volume":"40","author":"SL Wood","year":"2014","unstructured":"Wood, S. L., Pernemalm, M., Crosbie, P. A. & Whetton, A. D. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat. Rev. 40, 558\u2013566 (2014).","journal-title":"Cancer Treat. Rev."},{"key":"66817_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","volume":"32","author":"CS Dela Cruz","year":"2011","unstructured":"Dela Cruz, C. S., Tanoue, L. T. & Matthay, R. A. Lung cancer: epidemiology, etiology, and prevention. Clin. Chest Med. 32, 605\u2013644 (2011).","journal-title":"Clin. Chest Med."},{"key":"66817_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2174\/1389450124666230731094837","volume":"24","author":"J Sebastian","year":"2023","unstructured":"Sebastian, J. & Rathinasamy, K. Microtubules and cell division: potential pharmacological targets in cancer therapy. Curr. Drug Targets 24, 889\u2013918 (2023).","journal-title":"Curr. Drug Targets"},{"key":"66817_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/EBC20190016","volume":"63","author":"C Garcin","year":"2019","unstructured":"Garcin, C. & Straube, A. Microtubules in cell migration. Essays Biochem. 63, 509\u2013520 (2019).","journal-title":"Essays Biochem."},{"key":"66817_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","volume":"22","author":"NB Gudimchuk","year":"2021","unstructured":"Gudimchuk, N. B. & McIntosh, J. R. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat. Rev. Mol. Cell Biol. 22, 777\u2013795 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"66817_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.devcel.2020.06.008","volume":"54","author":"A Roll-Mecak","year":"2020","unstructured":"Roll-Mecak, A. The tubulin code in microtubule dynamics and information encoding. Dev. Cell 54, 7\u201320 (2020).","journal-title":"Dev. Cell"},{"key":"66817_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/cells9112356","volume":"9","author":"D Lopes","year":"2020","unstructured":"Lopes, D. & Maiato, H. The tubulin code in mitosis and cancer. Cells 9, 2356 (2020).","journal-title":"Cells"},{"key":"66817_CR10","doi-asserted-by":"publisher","first-page":"105320","DOI":"10.1016\/j.bioorg.2021.105320","volume":"116","author":"S Khwaja","year":"2021","unstructured":"Khwaja, S., Kumar, K., Das, R. & Negi, A. S. Microtubule associated proteins as targets for anticancer drug development. Bioorg. Chem. 116, 105320 (2021).","journal-title":"Bioorg. Chem."},{"key":"66817_CR11","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1021\/acs.jmedchem.6b00463","volume":"59","author":"M-J P\u00e9rez-P\u00e9rez","year":"2016","unstructured":"P\u00e9rez-P\u00e9rez, M.-J. et al. Blocking blood flow to solid tumors by destabilizing tubulin: an approach to targeting tumor growth. J. Med. Chem. 59, 8685\u20138711 (2016).","journal-title":"J. Med. Chem."},{"key":"66817_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113282","volume":"215","author":"J Krzywik","year":"2021","unstructured":"Krzywik, J. et al. An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine. Eur. J. Med. Chem. 215, 113282 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"66817_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","volume":"28","author":"MO Steinmetz","year":"2018","unstructured":"Steinmetz, M. O. & Prota, A. E. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol. 28, 776\u2013792 (2018).","journal-title":"Trends Cell Biol."},{"key":"66817_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112105","volume":"190","author":"Y-Y Shao","year":"2020","unstructured":"Shao, Y.-Y. et al. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Eur. J. Med. Chem. 190, 112105 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"66817_CR15","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.3390\/cancers13225650","volume":"13","author":"L Wordeman","year":"2021","unstructured":"Wordeman, L. & Vicente, J. J. Microtubule targeting agents in disease: classic drugs, novel roles. Cancers 13, 5650 (2021).","journal-title":"Cancers"},{"key":"66817_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1021\/acs.jnatprod.9b00105","volume":"82","author":"R Kaul","year":"2019","unstructured":"Kaul, R., Risinger, A. L. & Mooberry, S. L. Microtubule-targeting drugs: more than antimitotics. J. Nat. Prod. 82, 680\u2013685 (2019).","journal-title":"J. Nat. Prod."},{"key":"66817_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15384047.2017.1373217","volume":"18","author":"H Du","year":"2017","unstructured":"Du, H. et al. The roles of vasohibin and its family members: beyond angiogenesis modulators. Cancer Biol. Ther. 18, 827\u2013832 (2017).","journal-title":"Cancer Biol. Ther."},{"key":"66817_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/cas.13157","volume":"108","author":"R Norita","year":"2017","unstructured":"Norita, R. et al. Vasohibin-2 is required for epithelial\u2013mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-\u03b2 signaling. Cancer Sci. 108, 419\u2013426 (2017).","journal-title":"Cancer Sci."},{"key":"66817_CR19","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1002\/cam4.1752","volume":"7","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway. Cancer Med. 7, 5567\u20135576 (2018).","journal-title":"Cancer Med."},{"key":"66817_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/1574888X18666230417084221","volume":"19","author":"P Shayimu","year":"2024","unstructured":"Shayimu, P., Yin, C., Zeng, X. & Jiapaer, R. Knockdown of VASH2 inhibits the stemness and EMT process by regulating ZEB2 in colorectal cancer. Curr. Stem Cell Res. Ther. 19, 126\u2013132 (2024).","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"66817_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-014-0062-x","volume":"12","author":"X Xue","year":"2014","unstructured":"Xue, X. et al. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Commun. Signal 12, 62 (2014).","journal-title":"Cell Commun. Signal"},{"key":"66817_CR22","doi-asserted-by":"publisher","first-page":"S1075","DOI":"10.1016\/j.jtho.2018.10.087","volume":"13","author":"P Liu","year":"2018","unstructured":"Liu, P. Study on the mechanisms of VASH2\/TGF-\u03b2\/VEGF-D in promoting the lymph node metastasis of lung squamous cell carcinoma. J. Thorac. Oncol. 13, S1075 (2018).","journal-title":"J. Thorac. Oncol."},{"key":"66817_CR23","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0016-5085(16)30250-5","volume":"150","author":"A Overby","year":"2016","unstructured":"Overby, A., Takahashi, T., Matsui, H. & Nakamura, M. Angiogenesis and MALT lymphoma in stomach, liver and salivary gland: interaction with Vash2 and VEGF. Gastroenterology 150, S37 (2016).","journal-title":"Gastroenterology"},{"key":"66817_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.aao5676","volume":"358","author":"J Nieuwenhuis","year":"2017","unstructured":"Nieuwenhuis, J. et al. Vasohibins encode tubulin detyrosinating activity. Science 358, 1453\u20131456 (2017).","journal-title":"Science"},{"key":"66817_CR25","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.aao4165","volume":"358","author":"C Aillaud","year":"2017","unstructured":"Aillaud, C. et al. Vasohibins\/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation. Science 358, 1448\u20131453 (2017).","journal-title":"Science"},{"key":"66817_CR26","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202205096","volume":"222","author":"S Ramirez-Rios","year":"2022","unstructured":"Ramirez-Rios, S. et al. VASH1\u2013SVBP and VASH2\u2013SVBP generate different detyrosination profiles on microtubules. J. Cell Biol. 222, e202205096 (2022).","journal-title":"J. Cell Biol."},{"key":"66817_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11277-8","volume":"10","author":"C Zhou","year":"2019","unstructured":"Zhou, C., Yan, L., Zhang, W. & Liu, Z. Structural basis of tubulin detyrosination by VASH2\/SVBP heterodimer. Nat. Commun. 10, 1\u20138 (2019).","journal-title":"Nat. Commun."},{"key":"66817_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel, D. P. Metazoan MicroRNAs. Cell 173, 20\u201351 (2018).","journal-title":"Cell"},{"key":"66817_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1152\/physiolgenomics.00062.2019","volume":"51","author":"L Sun","year":"2019","unstructured":"Sun, L., Chen, T., Li, T. & Yu, J. LncRNA IUR downregulates ZEB1 by upregulating miR-200 to inhibit prostate carcinoma. Physiol. Genomics 51, 607\u2013611 (2019).","journal-title":"Physiol. Genomics"},{"key":"66817_CR30","doi-asserted-by":"publisher","first-page":"114243","DOI":"10.1016\/j.ab.2021.114243","volume":"626","author":"B Wen","year":"2021","unstructured":"Wen, B., Zhu, R., Jin, H. & Zhao, K. Differential expression and role of miR-200 family in multiple tumors. Anal. Biochem. 626, 114243 (2021).","journal-title":"Anal. Biochem."},{"key":"66817_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07130-z","volume":"9","author":"AC Title","year":"2018","unstructured":"Title, A. C. et al. Genetic dissection of the miR-200\u2013Zeb1 axis reveals its importance in tumor differentiation and invasion. Nat. Commun. 9, 4671 (2018).","journal-title":"Nat. Commun."},{"key":"66817_CR32","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1101\/gad.1820209","volume":"23","author":"DL Gibbons","year":"2009","unstructured":"Gibbons, D. L. et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 23, 2140\u20132151 (2009).","journal-title":"Genes Dev."},{"key":"66817_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3427","volume":"4","author":"CV Pecot","year":"2013","unstructured":"Pecot, C. V. et al. Tumour angiogenesis regulation by the miR-200 family. Nat. Commun. 4, 2427 (2013).","journal-title":"Nat. Commun."},{"key":"66817_CR34","doi-asserted-by":"publisher","first-page":"e87780","DOI":"10.1371\/journal.pone.0087780","volume":"9","author":"W Zhu","year":"2014","unstructured":"Zhu, W. et al. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One 9, e87780 (2014).","journal-title":"PLoS One"},{"key":"66817_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gad.347344.120","volume":"35","author":"B Xue","year":"2021","unstructured":"Xue, B. et al. miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts. Genes Dev. 35, 1109\u20131122 (2021).","journal-title":"Genes Dev."},{"key":"66817_CR36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41416-021-01568-7","volume":"125","author":"S Garinet","year":"2021","unstructured":"Garinet, S. et al. Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC. Br. J. Cancer 125, 1544\u20131551 (2021).","journal-title":"Br. J. Cancer"},{"key":"66817_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12323","volume":"24","author":"L Cao","year":"2021","unstructured":"Cao, L., Zhou, X., Ding, X. & Gao, D. Knockdown of circ\u2011PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR\u2011429\/FOXK1 signaling axis. Mol. Med. Rep. 24, 1\u201311 (2021).","journal-title":"Mol. Med. Rep."},{"key":"66817_CR38","doi-asserted-by":"publisher","first-page":"16774","DOI":"10.1021\/acs.jmedchem.2c01595","volume":"65","author":"J Leng","year":"2022","unstructured":"Leng, J. et al. Discovery of novel N-heterocyclic-fused deoxypodophyllotoxin analogues as tubulin polymerization inhibitors targeting the colchicine-binding site for cancer treatment. J. Med. Chem. 65, 16774\u201316800 (2022).","journal-title":"J. Med. Chem."},{"key":"66817_CR39","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1021\/acs.jmedchem.6b00071","volume":"59","author":"Y-N Liu","year":"2016","unstructured":"Liu, Y.-N. et al. Design, synthesis, and biological evaluation of 1-methyl-1,4-dihydroindeno[1,2-c]pyrazole analogues as potential anticancer agents targeting tubulin colchicine binding site. J. Med. Chem. 59, 5341\u20135355 (2016).","journal-title":"J. Med. Chem."},{"key":"66817_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1129","volume":"13","author":"QW Chen","year":"2023","unstructured":"Chen, Q. W. et al. LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing. Clin. Transl. Med. 13, e1129 (2023).","journal-title":"Clin. Transl. Med."},{"key":"66817_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2016.08.009","volume":"42","author":"G Cantelli","year":"2017","unstructured":"Cantelli, G., Crosas-Molist, E., Georgouli, M. & Sanz-Moreno, V. TGF\u0392-induced transcription in cancer. Semin Cancer Biol. 42, 60\u201369 (2017).","journal-title":"Semin Cancer Biol."},{"key":"66817_CR42","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak, I. et al. Role of cadherins in cancer\u2014a review. Int. J. Mol. Sci. 21, 7624 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"66817_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41594-019-0241-y","volume":"26","author":"N Wang","year":"2019","unstructured":"Wang, N. et al. Structural basis of tubulin detyrosination by the vasohibin\u2013SVBP enzyme complex. Nat. Struct. Mol. Biol. 26, 571\u2013582 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66817_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41594-019-0242-x","volume":"26","author":"F Li","year":"2019","unstructured":"Li, F., Hu, Y., Qi, S., Luo, X. & Yu, H. Structural basis of tubulin detyrosination by vasohibins. Nat. Struct. Mol. Biol. 26, 583\u2013591 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66817_CR45","doi-asserted-by":"publisher","first-page":"v\u2013vi","DOI":"10.1038\/nmeth.f.306","volume":"7","author":"M Gullberg","year":"2010","unstructured":"Gullberg, M. & Andersson, A.-C. Visualization and quantification of protein\u2013protein interactions in cells and tissues. Nat. Methods 7, v\u2013vi (2010).","journal-title":"Nat. Methods"},{"key":"66817_CR46","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","volume":"68","author":"CP Bracken","year":"2008","unstructured":"Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846\u20137854 (2008).","journal-title":"Cancer Res."},{"key":"66817_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu, W. & Wang, X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 20, 18 (2019).","journal-title":"Genome Biol."},{"key":"66817_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J.-W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, e05005 (2015).","journal-title":"eLife"},{"key":"66817_CR49","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"J-H Li","year":"2014","unstructured":"Li, J.-H., Liu, S., Zhou, H., Qu, L.-H. & Yang, J.-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92\u2013D97 (2014).","journal-title":"Nucleic Acids Res."},{"key":"66817_CR50","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.1021\/acsomega.2c00840","volume":"7","author":"ZE Gunyuz","year":"2022","unstructured":"Gunyuz, Z. E. et al. SEMA6D differentially regulates proliferation, migration, and invasion of breast cell lines. ACS Omega 7, 15769\u201315778 (2022).","journal-title":"ACS Omega"},{"key":"66817_CR51","first-page":"6923","volume":"14","author":"Y Chang","year":"2017","unstructured":"Chang, Y. et al. miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells. Oncol. Lett. 14, 6923\u20136928 (2017).","journal-title":"Oncol. Lett."},{"key":"66817_CR52","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41388-022-02211-2","volume":"41","author":"L-M Xu","year":"2022","unstructured":"Xu, L.-M. et al. MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG. Oncogene 41, 1742\u20131751 (2022).","journal-title":"Oncogene"},{"key":"66817_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07356-y","volume":"16","author":"A Wang","year":"2025","unstructured":"Wang, A. et al. Endoplasmic reticulum stress-related super enhancer promotes epithelial-mesenchymal transformation in hepatocellular carcinoma through CREB5 mediated activation of TNC. Cell Death Dis. 16, 73 (2025).","journal-title":"Cell Death Dis."},{"key":"66817_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature02393","volume":"428","author":"RBG Ravelli","year":"2004","unstructured":"Ravelli, R. B. G. et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428, 198\u2013202 (2004).","journal-title":"Nature"},{"key":"66817_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.21037\/jtd.2019.12.74","volume":"12","author":"D von Eiff","year":"2020","unstructured":"von Eiff, D. et al. Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients. J. Thorac. Dis. 12, 782\u2013793 (2020).","journal-title":"J. Thorac. Dis."},{"key":"66817_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/ijo.2023.5567","volume":"63","author":"Y Tian","year":"2023","unstructured":"Tian, Y. et al. Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review). Int J. Oncol. 63, 119 (2023).","journal-title":"Int J. Oncol."},{"key":"66817_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100951","volume":"68","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance. Drug Resist. Updates 68, 100951 (2023).","journal-title":"Drug Resist. Updates"},{"key":"66817_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.canlet.2007.07.022","volume":"257","author":"KM Wiesen","year":"2007","unstructured":"Wiesen, K. M., Xia, S., Yang, C.-P. H. & Horwitz, S. B. Wild-type class I \u03b2-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a \u03b2-tubulin mutation. Cancer Lett. 257, 227\u2013235 (2007).","journal-title":"Cancer Lett."},{"key":"66817_CR59","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1529\/biophysj.108.133884","volume":"95","author":"A Mitra","year":"2008","unstructured":"Mitra, A. & Sept, D. Taxol allosterically alters the dynamics of the tubulin dimer and increases the flexibility of microtubules. Biophys. J. 95, 3252\u20133258 (2008).","journal-title":"Biophys. J."},{"key":"66817_CR60","doi-asserted-by":"publisher","first-page":"e0221532","DOI":"10.1371\/journal.pone.0221532","volume":"14","author":"H Sahakyan","year":"2019","unstructured":"Sahakyan, H., Abelyan, N., Arakelov, V., Arakelov, G. & Nazaryan, K. In silico study of colchicine resistance molecular mechanisms caused by tubulin structural polymorphism. PLoS One 14, e0221532 (2019).","journal-title":"PLoS One"},{"key":"66817_CR61","doi-asserted-by":"publisher","first-page":"111450","DOI":"10.1016\/j.biopha.2021.111450","volume":"138","author":"S Xie","year":"2021","unstructured":"Xie, S., Wu, Z., Qi, Y., Wu, B. & Zhu, X. The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges. Biomed. Pharmacother. 138, 111450 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"66817_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pharmthera.2017.11.004","volume":"184","author":"P\u00d6 Eser","year":"2018","unstructured":"Eser, P. \u00d6 & J\u00e4nne, P. A. TGF\u03b2 pathway inhibition in the treatment of non-small cell lung cancer. Pharmacol. Ther. 184, 112\u2013130 (2018).","journal-title":"Pharmacol. Ther."},{"key":"66817_CR63","first-page":"427","volume":"15","author":"H-T Feng","year":"2017","unstructured":"Feng, H.-T., Zhao, W.-W., Lu, J.-J., Wang, Y.-T. & Chen, X.-P. Hypaconitine inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells. Chin. J. Nat. Med. 15, 427\u2013435 (2017).","journal-title":"Chin. J. Nat. Med."},{"key":"66817_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01240-9","volume":"20","author":"Q Wu","year":"2020","unstructured":"Wu, Q. et al. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway. Cancer Cell Int. 20, 172 (2020).","journal-title":"Cancer Cell Int."},{"key":"66817_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.8018","volume":"45","author":"H Liao","year":"2021","unstructured":"Liao, H. et al. miR\u2011454\u20113p inhibits non\u2011small cell lung cancer cell proliferation and metastasis by targeting TGFB2. Oncol. Rep. 45, 1\u201312 (2021).","journal-title":"Oncol. Rep."},{"key":"66817_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tcb.2018.08.003","volume":"29","author":"J Nieuwenhuis","year":"2019","unstructured":"Nieuwenhuis, J. & Brummelkamp, T. R. The tubulin detyrosination cycle: function and enzymes. Trends Cell Biol. 29, 80\u201392 (2019).","journal-title":"Trends Cell Biol."},{"key":"66817_CR67","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-018-0046-2","volume":"24","author":"CY Chen","year":"2018","unstructured":"Chen, C. Y. et al. Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure. Nat. Med. 24, 1225\u20131233 (2018).","journal-title":"Nat. Med."},{"key":"66817_CR68","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/cells12091266","volume":"12","author":"MB Stemberger","year":"2023","unstructured":"Stemberger, M. B. et al. Hydrogen peroxide induces \u03b1-tubulin detyrosination and acetylation and impacts breast cancer metastatic phenotypes. Cells 12, 1266 (2023).","journal-title":"Cells"},{"key":"66817_CR69","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1111\/1759-7714.13620","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. MiR-429 suppresses proliferation and invasion of breast cancer via inhibiting the Wnt\/\u03b2-catenin signaling pathway. Thorac. Cancer 11, 3126\u20133138 (2020).","journal-title":"Thorac. Cancer"},{"key":"66817_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7150\/thno.36274","volume":"10","author":"C Cava","year":"2020","unstructured":"Cava, C. et al. Theranostic application of miR-429 in HER2+ breast cancer. Theranostics 10, 50\u201361 (2020).","journal-title":"Theranostics"},{"key":"66817_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2014.05.084","volume":"450","author":"Y Lang","year":"2014","unstructured":"Lang, Y. et al. MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes. Biochem. Biophys. Res. Commun. 450, 154\u2013159 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"66817_CR72","doi-asserted-by":"publisher","first-page":"37250","DOI":"10.18632\/oncotarget.9363","volume":"7","author":"AR Halvorsen","year":"2016","unstructured":"Halvorsen, A. R. et al. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer. Oncotarget 7, 37250\u201337259 (2016).","journal-title":"Oncotarget"},{"key":"66817_CR73","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/acs.jmedchem.2c02115","volume":"66","author":"L Tan","year":"2023","unstructured":"Tan, L. et al. Design, synthesis, and biological evaluation of heterocyclic-fused pyrimidine chemotypes guided by X-ray crystal structure with potential antitumor and anti-multidrug resistance efficacy targeting the colchicine binding site. J. Med. Chem. 66, 3588\u20133620 (2023).","journal-title":"J. Med. Chem."},{"key":"66817_CR74","doi-asserted-by":"crossref","unstructured":"Kabsch, W. XDS. Acta Cryst D Biol. Crystallogr. 66, 125\u2013132 (2010).","DOI":"10.1107\/S0907444909047337"},{"key":"66817_CR75","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Cryst. D 69, 1204\u20131214 (2013).","journal-title":"Acta Cryst. D"},{"key":"66817_CR76","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"CNCB-NGDC Members and Partners","year":"2022","unstructured":"CNCB-NGDC Members and Partners Database resources of the national genomics data center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 50, D27\u2013D38 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66817-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:03:27Z","timestamp":1767801807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66817-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66817"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66817-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}